In this report, the United States Glutamate Carboxypeptidase 2 market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Glutamate Carboxypeptidase 2 in these regions, from 2013 to 2025 (forecast).
United States Glutamate Carboxypeptidase 2 market competition by top manufacturers/players, with Glutamate Carboxypeptidase 2 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Cerecor Inc
Crescendo Biologics Ltd
Eisai Co Ltd
Inovio Pharmaceuticals Inc
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
INO-5150
E-2072
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Prostate Cancer
Neuropathic Pain
Congnitive Impairment
Glioblastoma Multiforme
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Glutamate Carboxypeptidase 2 Market Report 2018
1 Glutamate Carboxypeptidase 2 Overview
1.1 Product Overview and Scope of Glutamate Carboxypeptidase 2
1.2 Classification of Glutamate Carboxypeptidase 2 by Product Category
1.2.1 United States Glutamate Carboxypeptidase 2 Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Glutamate Carboxypeptidase 2 Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 INO-5150
1.2.4 E-2072
1.2.5 Others
1.3 United States Glutamate Carboxypeptidase 2 Market by Application/End Users
1.3.1 United States Glutamate Carboxypeptidase 2 Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Prostate Cancer
1.3.3 Neuropathic Pain
1.3.4 Congnitive Impairment
1.3.5 Glioblastoma Multiforme
1.3.6 Others
1.4 United States Glutamate Carboxypeptidase 2 Market by Region
1.4.1 United States Glutamate Carboxypeptidase 2 Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Glutamate Carboxypeptidase 2 Status and Prospect (2013-2025)
1.4.3 Southwest Glutamate Carboxypeptidase 2 Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Glutamate Carboxypeptidase 2 Status and Prospect (2013-2025)
1.4.5 New England Glutamate Carboxypeptidase 2 Status and Prospect (2013-2025)
1.4.6 The South Glutamate Carboxypeptidase 2 Status and Prospect (2013-2025)
1.4.7 The Midwest Glutamate Carboxypeptidase 2 Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Glutamate Carboxypeptidase 2 (2013-2025)
1.5.1 United States Glutamate Carboxypeptidase 2 Sales and Growth Rate (2013-2025)
1.5.2 United States Glutamate Carboxypeptidase 2 Revenue and Growth Rate (2013-2025)
2 United States Glutamate Carboxypeptidase 2 Market Competition by Players/Suppliers
2.1 United States Glutamate Carboxypeptidase 2 Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Glutamate Carboxypeptidase 2 Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Glutamate Carboxypeptidase 2 Average Price by Players/Suppliers (2013-2018)
2.4 United States Glutamate Carboxypeptidase 2 Market Competitive Situation and Trends
2.4.1 United States Glutamate Carboxypeptidase 2 Market Concentration Rate
2.4.2 United States Glutamate Carboxypeptidase 2 Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Glutamate Carboxypeptidase 2 Manufacturing Base Distribution, Sales Area, Product Type
3 United States Glutamate Carboxypeptidase 2 Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Glutamate Carboxypeptidase 2 Sales and Market Share by Region (2013-2018)
3.2 United States Glutamate Carboxypeptidase 2 Revenue and Market Share by Region (2013-2018)
3.3 United States Glutamate Carboxypeptidase 2 Price by Region (2013-2018)
4 United States Glutamate Carboxypeptidase 2 Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Glutamate Carboxypeptidase 2 Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Glutamate Carboxypeptidase 2 Revenue and Market Share by Type (2013-2018)
4.3 United States Glutamate Carboxypeptidase 2 Price by Type (2013-2018)
4.4 United States Glutamate Carboxypeptidase 2 Sales Growth Rate by Type (2013-2018)
5 United States Glutamate Carboxypeptidase 2 Sales (Volume) by Application (2013-2018)
5.1 United States Glutamate Carboxypeptidase 2 Sales and Market Share by Application (2013-2018)
5.2 United States Glutamate Carboxypeptidase 2 Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Glutamate Carboxypeptidase 2 Players/Suppliers Profiles and Sales Data
6.1 Cerecor Inc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Glutamate Carboxypeptidase 2 Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Cerecor Inc Glutamate Carboxypeptidase 2 Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Crescendo Biologics Ltd
6.2.2 Glutamate Carboxypeptidase 2 Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Eisai Co Ltd
6.3.2 Glutamate Carboxypeptidase 2 Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eisai Co Ltd Glutamate Carboxypeptidase 2 Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Inovio Pharmaceuticals Inc
6.4.2 Glutamate Carboxypeptidase 2 Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
...
7 Glutamate Carboxypeptidase 2 Manufacturing Cost Analysis
7.1 Glutamate Carboxypeptidase 2 Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Glutamate Carboxypeptidase 2
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Glutamate Carboxypeptidase 2 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Glutamate Carboxypeptidase 2 Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Glutamate Carboxypeptidase 2 Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Glutamate Carboxypeptidase 2 Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Glutamate Carboxypeptidase 2 Sales Volume Forecast by Type (2018-2025)
11.3 United States Glutamate Carboxypeptidase 2 Sales Volume Forecast by Application (2018-2025)
11.4 United States Glutamate Carboxypeptidase 2 Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Glutamate Carboxypeptidase 2
Figure United States Glutamate Carboxypeptidase 2 Market Size (K Pcs) by Type (2013-2025)
Figure United States Glutamate Carboxypeptidase 2 Sales Volume Market Share by Type (Product Category) in 2017
Figure INO-5150 Product Picture
Figure E-2072 Product Picture
Figure Others Product Picture
Figure United States Glutamate Carboxypeptidase 2 Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Glutamate Carboxypeptidase 2 by Application in 2017
Figure Prostate Cancer Examples
Table Key Downstream Customer in Prostate Cancer
Figure Neuropathic Pain Examples
Table Key Downstream Customer in Neuropathic Pain
Figure Congnitive Impairment Examples
Table Key Downstream Customer in Congnitive Impairment
Figure Glioblastoma Multiforme Examples
Table Key Downstream Customer in Glioblastoma Multiforme
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Glutamate Carboxypeptidase 2 Market Size (Million USD) by Region (2013-2025)
Figure The West Glutamate Carboxypeptidase 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Glutamate Carboxypeptidase 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Glutamate Carboxypeptidase 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Glutamate Carboxypeptidase 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Glutamate Carboxypeptidase 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Glutamate Carboxypeptidase 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Glutamate Carboxypeptidase 2 Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Glutamate Carboxypeptidase 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Glutamate Carboxypeptidase 2 Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Glutamate Carboxypeptidase 2 Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Glutamate Carboxypeptidase 2 Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Glutamate Carboxypeptidase 2 Sales Share by Players/Suppliers
Figure 2017 United States Glutamate Carboxypeptidase 2 Sales Share by Players/Suppliers
Figure United States Glutamate Carboxypeptidase 2 Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Glutamate Carboxypeptidase 2 Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Glutamate Carboxypeptidase 2 Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Glutamate Carboxypeptidase 2 Revenue Share by Players/Suppliers
Figure 2017 United States Glutamate Carboxypeptidase 2 Revenue Share by Players/Suppliers
Table United States Market Glutamate Carboxypeptidase 2 Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Glutamate Carboxypeptidase 2 Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Glutamate Carboxypeptidase 2 Market Share of Top 3 Players/Suppliers
Figure United States Glutamate Carboxypeptidase 2 Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Glutamate Carboxypeptidase 2 Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Glutamate Carboxypeptidase 2 Product Category
Table United States Glutamate Carboxypeptidase 2 Sales (K Pcs) by Region (2013-2018)
Table United States Glutamate Carboxypeptidase 2 Sales Share by Region (2013-2018)
Figure United States Glutamate Carboxypeptidase 2 Sales Share by Region (2013-2018)
Figure United States Glutamate Carboxypeptidase 2 Sales Market Share by Region in 2017
Table United States Glutamate Carboxypeptidase 2 Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Glutamate Carboxypeptidase 2 Revenue Share by Region (2013-2018)
Figure United States Glutamate Carboxypeptidase 2 Revenue Market Share by Region (2013-2018)
Figure United States Glutamate Carboxypeptidase 2 Revenue Market Share by Region in 2017
Table United States Glutamate Carboxypeptidase 2 Price (USD/Pcs) by Region (2013-2018)
Table United States Glutamate Carboxypeptidase 2 Sales (K Pcs) by Type (2013-2018)
Table United States Glutamate Carboxypeptidase 2 Sales Share by Type (2013-2018)
Figure United States Glutamate Carboxypeptidase 2 Sales Share by Type (2013-2018)
Figure United States Glutamate Carboxypeptidase 2 Sales Market Share by Type in 2017
Table United States Glutamate Carboxypeptidase 2 Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Glutamate Carboxypeptidase 2 Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Glutamate Carboxypeptidase 2 by Type (2013-2018)
Figure Revenue Market Share of Glutamate Carboxypeptidase 2 by Type in 2017
Table United States Glutamate Carboxypeptidase 2 Price (USD/Pcs) by Types (2013-2018)
Figure United States Glutamate Carboxypeptidase 2 Sales Growth Rate by Type (2013-2018)
Table United States Glutamate Carboxypeptidase 2 Sales (K Pcs) by Application (2013-2018)
Table United States Glutamate Carboxypeptidase 2 Sales Market Share by Application (2013-2018)
Figure United States Glutamate Carboxypeptidase 2 Sales Market Share by Application (2013-2018)
Figure United States Glutamate Carboxypeptidase 2 Sales Market Share by Application in 2017
Table United States Glutamate Carboxypeptidase 2 Sales Growth Rate by Application (2013-2018)
Figure United States Glutamate Carboxypeptidase 2 Sales Growth Rate by Application (2013-2018)
Table Cerecor Inc Basic Information List
Table Cerecor Inc Glutamate Carboxypeptidase 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cerecor Inc Glutamate Carboxypeptidase 2 Sales Growth Rate (2013-2018)
Figure Cerecor Inc Glutamate Carboxypeptidase 2 Sales Market Share in United States (2013-2018)
Figure Cerecor Inc Glutamate Carboxypeptidase 2 Revenue Market Share in United States (2013-2018)
Table Crescendo Biologics Ltd Basic Information List
Table Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Sales Growth Rate (2013-2018)
Figure Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Sales Market Share in United States (2013-2018)
Figure Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Revenue Market Share in United States (2013-2018)
Table Eisai Co Ltd Basic Information List
Table Eisai Co Ltd Glutamate Carboxypeptidase 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eisai Co Ltd Glutamate Carboxypeptidase 2 Sales Growth Rate (2013-2018)
Figure Eisai Co Ltd Glutamate Carboxypeptidase 2 Sales Market Share in United States (2013-2018)
Figure Eisai Co Ltd Glutamate Carboxypeptidase 2 Revenue Market Share in United States (2013-2018)
Table Inovio Pharmaceuticals Inc Basic Information List
Table Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Sales Growth Rate (2013-2018)
Figure Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Sales Market Share in United States (2013-2018)
Figure Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glutamate Carboxypeptidase 2
Figure Manufacturing Process Analysis of Glutamate Carboxypeptidase 2
Figure Glutamate Carboxypeptidase 2 Industrial Chain Analysis
Table Raw Materials Sources of Glutamate Carboxypeptidase 2 Major Players/Suppliers in 2017
Table Major Buyers of Glutamate Carboxypeptidase 2
Table Distributors/Traders List
Figure United States Glutamate Carboxypeptidase 2 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Glutamate Carboxypeptidase 2 Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Glutamate Carboxypeptidase 2 Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Glutamate Carboxypeptidase 2 Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Glutamate Carboxypeptidase 2 Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Glutamate Carboxypeptidase 2 Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Glutamate Carboxypeptidase 2 Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Glutamate Carboxypeptidase 2 Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Glutamate Carboxypeptidase 2 Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Glutamate Carboxypeptidase 2 Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Glutamate Carboxypeptidase 2 Sales Volume Share Forecast by Region (2018-2025)
Figure United States Glutamate Carboxypeptidase 2 Sales Volume Share Forecast by Region (2018-2025)
Figure United States Glutamate Carboxypeptidase 2 Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
